Gladstone NOW: The Campaign Join Us on the Journey ✕
376 - 390 of 407 Results Clear All
San Francisco Business Times—For companies working on a certain approach to Alzheimer’s disease, the findings could expand targets.
Gladstone Experts
MedPage Today—Senior Investigator Warner Greene talks to MedPage Today about the coronavirus outbreak and research that could lay the groundwork for potential therapies.
Gladstone Experts COVID-19 Infectious Disease Greene Lab
Gladstone researchers are collaborating to solve cardiovascular diseases using new technologies.
Gladstone Experts Research (Publication) Heart Failure Congenital Heart Disease Cardiovascular Disease Data Science and Biotechnology Infectious Disease Bruneau Lab Conklin Lab Krogan Lab
Why should athletes and sports fans have all the fun in March?
Gladstone Experts Institutional News Huang Lab Srivastava Lab
STAT—Two Gladstone studies have been selected to participate in STAT Madness—a March Madness-style competition for scientific papers. Voting begins March 2, 2020.
Gladstone Experts Huang Lab Srivastava Lab
Aging is the single greatest risk factor for developing Alzheimer’s disease, Parkinson’s disease, and other brain diseases.
Gladstone Experts Cardiovascular Disease Neurological Disease Finkbeiner Lab McDevitt Lab Srivastava Lab Aging
From penicillin to organ transplants, so many important discoveries have dramatically changed healthcare and medicine over the past decades. But what’s really behind all this progress?
Gladstone Experts Research (Publication) Cardiovascular Disease Data Science and Biotechnology Pollard Lab Srivastava Lab Yamanaka Lab
Gladstone Senior Investigators Warner Greene and Melanie Ott teamed up with Charles Chiu of UCSF to host a public briefing on the coronavirus outbreak.
Gladstone Experts COVID-19 Infectious Disease Greene Lab Ott Lab
KQED—KQED features Gladstone's special public briefing on the coronavirus outbreak. Gladstone Senior Investigators Warner Greene and Melanie Ott break down what coronavirus is and what's being done to curb the outbreak.
Gladstone Experts Infectious Disease Greene Lab Ott Lab
Two Gladstone virologists use their expertise to answer the most common questions about the coronavirus outbreak.
Gladstone Experts COVID-19 Infectious Disease Greene Lab Ott Lab
Alzheimer’s News Today—Gladstone scientists recently received $4.8 million from the NIH to study how the protein apoE4 causes neurodegeneration in Alzheimer's disease.
Gladstone Experts Mahley Lab
San Francisco Business Times—Why time and patents could stand in the way of Bay Area companies working on ways to block the spread of the coronavirus.
Gladstone Experts
ABC News—ABC 7 Bay Area covered Gladstone's public briefing on the coronavirus outbreak. Gladstone Senior Investigators Warner Greene and Melanie Ott aim to arm the public with facts rather than inciting panic.
Gladstone Experts Infectious Disease Greene Lab Ott Lab
CMTA—Gladstone Senior Investigator Bruce Conklin and Luke Judge from UC San Francisco recently received a grant from the Charcot-Marie-Tooth Association to develop the gene-editing technique known as CRISPR for application to CMT2A, 2E, and 2F.
Gladstone Experts Conklin Lab
France 24—On France 24, Gladstone President Deepak Srivastava explains CRISPR technology and the potential is has to cure disease.
Gladstone Experts Srivastava Lab
